文献速递儿童呼吸

改善住院儿童哮喘诊疗路径(PIPA):一项多中心全国性研究

Pathways for Improving Inpatient Pediatric Asthma Care (PIPA): A Multicenter, National Study.
PubMed 文献 · Pediatrics · 2020-05-06

路径与早期使用定量吸入器(OR 1.18,95%CI 1.14-1.22)及转介戒烟资源(OR 1.93,95%CI 1.27-2.91)增加相关,但住院时长无显著变化(率比1.00,95%CI 0.96-1.06)。

要点

  • 路径实施与早期使用定量吸入器及转介戒烟资源增加相关。
  • 住院时长(LOS)无显著变化(率比1.00,95%CI 0.96-1.06)。
  • 65%的医院在至少1项结局上有改善。

核心结论

  • 路径未显著影响住院时长,但改善了多样化全国医院样本中儿童哮喘的诊疗质量。

研究设计与样本

  • 纳入2至17岁以哮喘为主要诊断住院的儿童,每家医院每月回顾最多20份病历,覆盖实施前12个月和实施后15个月。
  • 采用多水平回归模型中断时间序列分析,调整患者特征。

主要发现

  • 路径与早期使用定量吸入器增加相关(OR 1.18;95%CI 1.14-1.22)。
  • 路径与转介戒烟资源增加相关(OR 1.93;95%CI 1.27-2.91)。
  • 住院时长无统计学显著变化(率比1.00;95%CI 0.96-1.06)。
  • 其他结局无统计学显著变化。
  • 65%的医院在至少1项结局上有改善。

关键数值与推荐

  • 路径实施策略包括本地倡导者、外部促进者/导师、教育研讨会、质量改进方法以及审计与反馈。
  • 主要结局为住院时长,次要结局包括早期使用定量吸入器、二手烟暴露筛查及转介戒烟资源,平衡指标为7天内再住院或急诊再访。

临床怎么用

  • 在多样化的医院环境中实施住院儿童哮喘路径可改善早期使用定量吸入器和戒烟资源转介等诊疗过程。
  • 路径实施未必能缩短住院时长,临床应关注过程质量指标的提升。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Pathways guide clinicians through evidence-based care of specific conditions. Pathways have been demonstrated to improve inpatient asthma care but mainly in studies at large, tertiary children's hospitals. It remains unclear if these effects are generalizable across diverse hospital settings. Our objective was to improve inpatient asthma care by implementing pathways in a diverse, national sample of hospitals. METHODS: We used a learning collaborative model. Pathway implementation strategies included local champions, external facilitators and/or mentors, educational seminars, quality improvement methods, and audit and feedback. Outcomes included length of stay (LOS) (primary), early administration of metered-dose inhalers, screening for secondhand tobacco exposure and referral to cessation resources, and 7-day hospital readmissions or emergency revisits (balancing). Hospitals reviewed a sample of up to 20 charts per month of children ages 2 to 17 years who were admitted with a primary diagnosis of asthma (12 months before and 15 months after implementation). Analyses were done by using multilevel regression models with an interrupted time series approach, adjusting for patient characteristics. RESULTS: Eighty-five hospitals enrolled (40 children's and 45 community); 68 (80%) completed the study (n = 12 013 admissions). Pathways were associated with increases in early administration of metered-dose inhalers (odds ratio: 1.18; 95% confidence interval [CI]: 1.14-1.22) and referral to smoking cessation resources (odds ratio: 1.93; 95% CI: 1.27-2.91) but no statistically significant changes in other outcomes, including LOS (rate ratio: 1.00; 95% CI: 0.96-1.06). Most hospitals (65%) improved in at least 1 outcome. CONCLUSIONS: Pathways did not significantly impact LOS but did improve quality of asthma care for children in a diverse, national group of hospitals.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Kaiser SV, Jennings B, Rodean J, et al. Pathways for Improving Inpatient Pediatric Asthma Care (PIPA): A Multicenter, National Study. Pediatrics. 2020. PMID: 32376727. doi:10.1542/peds.2019-3026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。